Discover scientific advancements, research, and discoveries in biology, physics, and chemistry.
Energy
Fervo Energy, a leader in advanced geothermal technology, has secured $206 million in new financing to accelerate development of what could become the world’s largest enhanced geothermal power plant. The announcement, made Wednesday, underscores growing investor confidence in enhanced geothermal energy as a viable, scalable clean power source—particularly
Quantum Computing
In a landmark announcement that could redefine the future of computation, IBM has unveiled its ambitious roadmap to deliver the world’s first large-scale, fault-tolerant quantum computer—IBM Quantum Starling—by 2029. This development marks a critical inflection point in the journey from experimental quantum prototypes to practical, scalable quantum
Energy
Nobody ever claimed that commercializing fusion energy would be fast—or cheap. But TAE Technologies, one of the most well-funded players in the fusion race, continues to push forward with substantial backing from deep-pocketed investors. This week, the company announced it raised an additional $150 million in a funding round
Robotics
Hugging Face, best known for its AI developer platform, has taken another major step into the world of robotics with the release of two new open-source humanoid robots: HopeJR and Reachy Mini. Announced Thursday, the robots are part of Hugging Face’s mission to democratize robotics and ensure that advanced
Biotechnology
Elon Musk’s brain-computer interface startup, Neuralink, has raised $600 million in a new funding round, pushing its pre-money valuation to $9 billion. The round marks a significant leap in valuation for the company, which was reportedly worth $5 billion less than a year ago. The identities of the investors
Biotechnology
Samsung’s venture capital arm is preparing to invest in California-based medical device startup Exo, as part of a funding round that could reach $100 million. The round is reportedly being led by Sands Capital, Bold Capital, and Qubit Health Capital. Notably, Qubit Health’s chairman, former Medtronic CEO Omar
Biotechnology
Pharmaceutical giant Regeneron announced Monday that it will acquire genetic testing company 23andMe for $256 million, following a court-supervised bankruptcy auction. The deal, if approved, will grant Regeneron ownership of 23andMe’s genomics service and a massive trove of personal and genetic data from roughly 15 million customers. The acquisition
Biotechnology
Biotech startup NewLimit, which is focused on extending healthy human lifespan through cellular reprogramming, has raised a $130 million Series B round led by Kleiner Perkins. The round also included new investors Nat Friedman, Daniel Gross, and Khosla Ventures, along with returning backers like Founders Fund, Dimension Capital, Elad Gil,
Biotechnology
Twelve thousand years after they vanished from the face of the Earth, dire wolves—once apex predators of the Ice Age—have returned. In a stunning scientific breakthrough, Colossal Biosciences, the ambitious de-extinction company known for its efforts to resurrect the woolly mammoth, announced the successful birth of three dire
Artificial Intelligence (AI)
Despite economic headwinds and geopolitical uncertainty, artificial intelligence continues to dominate the investment landscape. A prime example is Rescale, a rising force in AI-driven physics modeling, which just closed a $115 million Series D funding round. The round attracted a powerhouse roster of backers, including Nvidia and Foxconn, and added
Biotechnology
Isomorphic Labs, the artificial intelligence-driven drug discovery startup spun out of DeepMind, has secured $600 million in its first-ever external funding round. The financing, led by Thrive Capital with participation from Alphabet and its venture arm GV, marks a significant milestone for the Alphabet-owned company as it scales its efforts
Biotechnology
Once heralded as a trailblazer in consumer genetics, 23andMe has filed for Chapter 11 bankruptcy protection, marking a dramatic fall from its former $6 billion valuation. The filing was made Sunday night in Missouri federal court, capping off a tumultuous period for the company marked by financial struggles, failed business